Document ID: chunk:federal_register_of_legislation:C2005A00129:clause:1_155
Version: federal_register_of_legislation:C2005A00129
Segment Type: clause
Provision Reference: sch 1 cl 155
Character Range: 153485–156644

155                                     Trimeperidine                                                                                                                              10.0                 10.0

 (2) A substance is also a border controlled drug if the substance (the drug analogue) is, in relation to a border controlled drug listed in subsection (1) (or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a border controlled drug):
 (a) a stereoisomer; or
 (b) a structural isomer having the same constituent groups; or
 (c) an alkaloid; or
 (d) a structural modification obtained by the addition of one or more of the following groups:
 (i) alkoxy, cyclic diether, acyl, acyloxy, mono‑amino or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;
 (ii) alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;
 (iii) halogen, hydroxy, nitro or amino groups; or
 (e) a structural modification obtained in one or more of the following ways:
 (i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;
 (ii) by the addition of hydrogen atoms to one or more unsaturated bonds;
 (iii) by the replacement of one or more of the groups specified in paragraph (d) with another such group or groups;
 (iv) by the conversion of a carboxyl or an ester group into an amide group; or
 (f) otherwise a homologue, analogue, chemical derivative or substance substantially similar in chemical structure;
however obtained, except where the drug analogue is separately listed in subsection (1).

 (3) The marketable quantity for a drug analogue described in subsection (2) is:
 (a) unless paragraph (b) applies—the marketable quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or
 (b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1)—the smallest marketable quantity specified in the table in subsection (1) for any of those border controlled drugs.

 (4) The commercial quantity for a drug analogue described in subsection (2) is:
 (a) unless paragraph (b) applies—the commercial quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or
 (b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1)—the smallest commercial quantity specified in the table in subsection (1) for any of those border controlled drugs.

314.5  Border controlled plants

  The following table lists border controlled plants and sets out quantities:

Border controlled plants and quantities
                                         Border controlled plants                                                                                                                            Marketable quantity  Commercial quantity